Skip to main content
PMC home page
Protein & Cell logoLink to Protein & Cell
. 2010 Jul 29;1(7):688–697. doi: 10.1007/s13238-010-0079-x

Structures of the N- and C-terminal domains of MHV-A59 nucleocapsid protein corroborate a conserved RNA-protein binding mechanism in coronavirus

Yanlin Ma 1,2, Xiaohang Tong 1,2, Xiaoling Xu 3, Xuemei Li 1, Zhiyong Lou 3, Zihe Rao 1,3,✉
PMCID: PMC4875274  PMID: 21203940

Abstract

Coronaviruses are the causative agent of respiratory and enteric diseases in animals and humans. One example is SARS, which caused a worldwide health threat in 2003. In coronaviruses, the structural protein N (nucleocapsid protein) associates with the viral RNA to form the filamentous nucleocapsid and plays a crucial role in genome replication and transcription. The structure of Nterminal domain of MHV N protein also implicated its specific affinity with transcriptional regulatory sequence (TRS) RNA. Here we report the crystal structures of the two proteolytically resistant N- (NTD) and C-terminal (CTD) domains of the N protein from murine hepatitis virus (MHV). The structure of NTD in two different crystal forms was solved to 1.5 Å. The higher resolution provides more detailed structural information than previous reports, showing that the NTD structure from MHV shares a similar overall and topology structure with that of SARS-CoV and IBV, but varies in its potential surface, which indicates a possible difference in RNA-binding module. The structure of CTD was solved to 2.0-Å resolution and revealed a tightly intertwined dimer. This is consistent with analytical ultracentrifugation experiments, suggesting a dimeric assembly of the N protein. The similarity between the structures of these two domains from SARS-CoV, IBV and MHV corroborates a conserved mechanism of nucleocapsid formation for coronaviruses.

Keywords: crystal structure, nucleocapsid protein, murine hepatitis virus

Footnotes

These authors contributed equally to the work.

References

  1. Almazán F., Galán C., Enjuanes L. The nucleoprotein is required for efficient coronavirus genome replication. J Virol. 2004;78:12683–12688. doi: 10.1128/JVI.78.22.12683-12688.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Almazán F., González J.M., Pénzes Z., Izeta A., Calvo E., Plana-Durán J., Enjuanes L. Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A. 2000;97:5516–5521. doi: 10.1073/pnas.97.10.5516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bailey S., the Collaborative Computational Project, Number 4 The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr. 1994;50:760–763. doi: 10.1107/S0907444993011898. [DOI] [PubMed] [Google Scholar]
  4. Baric R.S., Nelson G.W., Fleming J.O., Deans R.J., Keck J.G., Casteel N., Stohlman S.A. Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription. J Virol. 1988;62:4280–4287. doi: 10.1128/jvi.62.11.4280-4287.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bednar V., Verma S., Blount A., Hogue B.G. Importance of MHV-CoVA59 nucleocapsid protein COOH-terminal negative charges. Adv Exp Med Biol. 2006;581:127–132. doi: 10.1007/978-0-387-33012-9_22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bost A.G., Carnahan R.H., Lu X.T., Denison M.R. Four proteins processed from the replicase gene polyprotein of mouse hepatitis virus colocalize in the cell periphery and adjacent to sites of virion assembly. J Virol. 2000;74:3379–3387. doi: 10.1128/JVI.74.7.3379-3387.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Casais R., Thiel V., Siddell S.G., Cavanagh D., Britton P. Reverse genetics system for the avian coronavirus infectious bronchitis virus. J Virol. 2001;75:12359–12369. doi: 10.1128/JVI.75.24.12359-12369.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chang C.K., Hsu Y.L., Chang Y.H., Chao F.A., Wu M.C., Huang Y. S., Hu C.K., Huang T.H. Multiple nucleic acid binding sites and intrinsic disorder of severe acute respiratory syndrome coronavirus nucleocapsid protein: implications for ribonucleocapsid protein packaging. J Virol. 2009;83:2255–2264. doi: 10.1128/JVI.02001-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chen C.Y., Chang C.K., Chang Y.W., Sue S.C., Bai H.I., Riang L., Hsiao C.D., Huang T.H. Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA. J Mol Biol. 2007;368:1075–1086. doi: 10.1016/j.jmb.2007.02.069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Coley S.E., Lavi E., Sawicki S.G., Fu L., Schelle B., Karl N., Siddell S.G., Thiel V. Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo. J Virol. 2005;79:3097–3106. doi: 10.1128/JVI.79.5.3097-3106.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cologna R., Spagnolo J.F., Hogue B.G. Identification of nucleocapsid binding sites within coronavirus-defective genomes. Virology. 2000;277:235–249. doi: 10.1006/viro.2000.0611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DeLano W. The PyMOL Molecular Graphics System. Palo Alto, CA, USA: DeLano Scientific; 2002. [Google Scholar]
  13. Drosten C., Günther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A., et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967–1976. doi: 10.1056/NEJMoa030747. [DOI] [PubMed] [Google Scholar]
  14. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
  15. Fan H., Ooi A., Tan Y.W., Wang S., Fang S., Liu D.X., Lescar J. The nucleocapsid protein of coronavirus infectious bronchitis virus: crystal structure of its N-terminal domain and multimerization properties. Structure. 2005;13:1859–1868. doi: 10.1016/j.str.2005.08.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fleischauer A.T., the Centers for Disease ControlPrevention Outbreak of severe acute respiratory syndrome—worldwide, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:226–228. [PubMed] [Google Scholar]
  17. Grossoehme N.E., Li L., Keane S.C., Liu P., Dann C.E., 3rd, Leibowitz J.L., Giedroc D.P. Coronavirus N protein Nterminal domain (NTD) specifically binds the transcriptional regulatory sequence (TRS) and melts TRS-cTRS RNA duplexes. J Mol Biol. 2009;394:544–557. doi: 10.1016/j.jmb.2009.09.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Huang Q., Yu L., Petros A., Gunasekera A., Liu Z., Xu N., Hajduk P., Mack J., Fesik S., Olejniczak E. Structure of the N-Terminal RNA-Binding domain of the SARS CoV nucleocapsid protein. Biochemisty. 2004;43:6059–6063. doi: 10.1021/bi036155b. [DOI] [PubMed] [Google Scholar]
  19. Hurst K.R., Kuo L., Koetzner C.A., Ye R., Hsue B., Masters P. S. A major determinant for membrane protein interaction localizes to the carboxy-terminal domain of the mouse coronavirus nucleocapsid protein. J Virol. 2005;79:13285–13297. doi: 10.1128/JVI.79.21.13285-13297.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Janin J., Chothia C. Minireview:The Structure of Protein-Protein Recognition Sites. J Biol Chem. 1990;265:16221–16224. [PubMed] [Google Scholar]
  21. Jayaram H., Fan H., Bowman B.R., Ooi A., Jayaram J., Collisson E.W., Lescar J., Prasad B.V.V. X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsid protein: implications for nucleocapsid formation. J Virol. 2006;80:6612–6620. doi: 10.1128/JVI.00157-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., the SARS Working Group et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953–1966. doi: 10.1056/NEJMoa030781. [DOI] [PubMed] [Google Scholar]
  23. Kuo L., Masters P.S. Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus. J Virol. 2002;76:4987–4999. doi: 10.1128/JVI.76.10.4987-4999.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lai M.M., Stohlman S.A. RNA of mouse hepatitis virus. J Virol. 1978;26:236–242. doi: 10.1128/jvi.26.2.236-242.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Laskowski R.A., Moss D.S., Thornton J.M. Main-chain bond lengths and bond angles in protein structures. J Mol Biol. 1993;231:1049–1067. doi: 10.1006/jmbi.1993.1351. [DOI] [PubMed] [Google Scholar]
  26. Luo H., Chen J., Chen K., Shen X., Jiang H. Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: self-association analysis and nucleic acid binding characterization. Biochemisty. 2006;45:11827–11835. doi: 10.1021/bi0609319. [DOI] [PubMed] [Google Scholar]
  27. Macneughton M.R., Davies H.A. Ribonucleoprotein-like structures from coronavirus particles. J Gen Virol. 1978;39:545–549. doi: 10.1099/0022-1317-39-3-545. [DOI] [PubMed] [Google Scholar]
  28. Masters P.S. Localization of an RNA-binding domain in the nucleocapsid protein of the coronavirus mouse hepatitis virus. Arch Virol. 1992;125:141–160. doi: 10.1007/BF01309634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., Read R.J. Phaser crystallographic software. J Appl Cryst. 2007;40:658–674. doi: 10.1107/S0021889807021206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mir M.A., Panganiban A.T. Characterization of the RNA chaperone activity of hantavirus nucleocapsid protein. J Virol. 2006;80:6276–6285. doi: 10.1128/JVI.00147-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Molenkamp R., Spaan W.J.M. Identification of a specific interaction between the coronavirus mouse hepatitis virus A59 nucleocapsid protein and packaging signal. Virology. 1997;239:78–86. doi: 10.1006/viro.1997.8867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nelson G.W., Stohlman S.A., Tahara S.M. High affinity interaction between nucleocapsid protein and leader/intergenic sequence of mouse hepatitis virus RNA. J Gen Virol. 2000;81:181–188. doi: 10.1099/0022-1317-81-1-181. [DOI] [PubMed] [Google Scholar]
  33. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in the oscillation mode. Methods Enzymol. 1997;276:307–326. doi: 10.1016/S0076-6879(97)76066-X. [DOI] [PubMed] [Google Scholar]
  34. Perrakis A., Morris R.M., Lamzin V.S. Automated protein model building combined with iterative structure refinement. Nat Struct Biol. 1999;6:458–463. doi: 10.1038/8263. [DOI] [PubMed] [Google Scholar]
  35. Robbins S.G., Frana M.F., McGowan J.J., Boyle J.F., Holmes K.V. RNA-binding proteins of coronavirus MHV: detection of monomeric and multimeric N protein with an RNA overlayprotein blot assay. Virology. 1986;150:402–410. doi: 10.1016/0042-6822(86)90305-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rota P., Oberste M., Monroe S., Nix W., Campagnoli R., Icenogle J., Peñaranda S., Bankamp B., Maher K., Chen M., et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300:1394–1399. doi: 10.1126/science.1085952. [DOI] [PubMed] [Google Scholar]
  37. Saikatendu K.S., Joseph J.S., Subramanian V., Neuman B.W., Buchmeier M.J., Stevens R.C., Kuhn P. Ribonucleocapsid formation of severe acute respiratory syndrome coronavirus through molecular action of the N-terminal domain of N protein. J Virol. 2007;81:3913–3921. doi: 10.1128/JVI.02236-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sawicki S.G., Sawicki D.L., Younker D., Meyer Y., Thiel V., Stokes H., Siddell S.G. Functional and genetic analysis of coronavirus replicase-transcriptase proteins. PLoS Pathog. 2005;1:e39. doi: 10.1371/journal.ppat.0010039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J. 2000;78:1606–1619. doi: 10.1016/S0006-3495(00)76713-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Stohlman S.A., Baric R.S., Nelson G.N., Soe L.H., Welter L.M., Deans R.J. Specific interaction between coronavirus leader RNA and nucleocapsid protein. J Virol. 1988;62:4288–4295. doi: 10.1128/jvi.62.11.4288-4295.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sturman L.S., Holmes K.V. The molecular biology of coronaviruses. Adv Virus Res. 1983;28:35–112. doi: 10.1016/S0065-3527(08)60721-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Takeda M., Chang C.K., Ikeya T., Güntert P., Chang Y.H., Hsu Y. L., Huang T.H., Kainosho M. Solution structure of the c-terminal dimerization domain of SARS coronavirus nucleocapsid protein solved by the SAIL-NMR method. J Mol Biol. 2008;380:608–622. doi: 10.1016/j.jmb.2007.11.093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Terwilliger T.C. Maximum-likelihood density modification. Acta Crystallogr D Biol Crystallogr. 2000;56:965–972. doi: 10.1107/S0907444900005072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Terwilliger T.C., Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr D Biol Crystallogr. 1999;55:849–861. doi: 10.1107/S0907444999000839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. van der Meer Y., Snijder E.J., Dobbe J.C., Schleich S., Denison M. R., Spaan W.J., Locker J.K. Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication. J Virol. 1999;73:7641–7657. doi: 10.1128/jvi.73.9.7641-7657.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Verma S., Bednar V., Blount A., Hogue B.G. Identification of functionally important negatively charged residues in the carboxy end of mouse hepatitis coronavirus A59 nucleocapsid protein. J Virol. 2006;80:4344–4355. doi: 10.1128/JVI.80.9.4344-4355.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. You J.-H., Reed M.L., Hiscox J.A. Trafficking motifs in the SARS-coronavirus nucleocapsid protein. Biochem Biophys Res Commun. 2007;358:1015–1020. doi: 10.1016/j.bbrc.2007.05.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Yu I.M., Oldham M.L., Zhang J., Chen J. Crystal structure of the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein dimerization domain reveals evolutionary linkage between corona- and arteriviridae. J Biol Chem. 2006;281:17134–17139. doi: 10.1074/jbc.M602107200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Zhang X., Liao C.-L., Lai M.M. Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. J Virol. 1994;68:4738–4746. doi: 10.1128/jvi.68.8.4738-4746.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Zúñiga S., Sola I., Moreno J.L., Sabella P., Plana-Durán J., Enjuanes L. Coronavirus nucleocapsid protein is an RNA chaperone. Virology. 2007;357:215–227. doi: 10.1016/j.virol.2006.07.046. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES